NEOGENOMICS INC — Director's Dealing 2020

Dec 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-12-11

Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-11	Common Stock	M	15000	$8.03	Acquired	39980	Direct
2020-12-11	Common Stock	S	15000	$49.99	Disposed	24980	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-11	Stock Option (Right to Buy)	$8.03	M	15000	Disposed	2023-02-26	Common Stock (15000.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (7000.0)	7000	Direct
Stock Option (Right to Buy)	$19.6	2024-03-01	Common Stock (17496.0)	17496	Direct
Stock Option (Right to Buy)	$28.33	2027-03-02	Common Stock (15006.0)	15006	Direct

Footnotes

F1: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.

F2: On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F3: On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F4: On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.